title: HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma.
abstract: Genotyping of hepatitis C virus (HCV) plays an important role in the treatment of HCV. As new genotype-specific treatment options become available, it has become increasingly important to have accurate HCV genotype and subtype information to ensure that the most appropriate treatment regimen is selected. Most current genotyping methods are unable to detect mixed genotypes from two or more HCV infections. Next generation sequencing (NGS) allows for rapid and low cost mass sequencing of viral genomes and provides an opportunity to probe the viral population from a single host. In this paper, the possibility of using short NGS reads for direct HCV genotyping without genome assembly was evaluated. We surveyed the publicly-available genetic content of three HCV drug target regions (NS3, NS5A, NS5B) in terms of whether these genes contained genotype-specific regions that could predict genotype. Six genotypes and 38 subtypes were included in this study. An automated phylogenetic analysis based HCV genotyping method was implemented and used to assess different HCV target gene regions. Candidate regions of 250-bp each were found for all three genes that have enough genetic information to predict HCV genotypes/subtypes. Validation using public datasets shows 100% genotyping accuracy. To test whether these 250-bp regions were sufficient to identify mixed genotypes, we developed a random primer-based method to sequence HCV plasma samples containing mixtures of two HCV genotypes in different ratios. We were able to determine the genotypes without ambiguity and to quantify the ratio of the abundances of the mixed genotypes in the samples. These data provide a proof-of-concept that this random primed, NGS-based short-read genotyping approach does not need prior information about the viral population and is capable of detecting mixed viral infection.
authors.affiliation: Molecular Biomarker and Diagnostics, Merck Research Laboratories, Rahway, New Jersey, United States of America.
authors.forename: Ping
authors.initials: P
authors.lastname: Qiu
authors.affiliation: Target & Pathway Biology, Merck Research Laboratories, Boston, Massachusetts, United States of America.
authors.forename: Richard
authors.initials: R
authors.lastname: Stevens
authors.affiliation: Molecular Biomarker and Diagnostics, Merck Research Laboratories, Rahway, New Jersey, United States of America.
authors.forename: Bo
authors.initials: B
authors.lastname: Wei
authors.affiliation: Infectious Diseases and Clinical Virology, Merck Research Laboratories, Kenilworth, New Jersey, United States of America.
authors.forename: Fred
authors.initials: F
authors.lastname: Lahser
authors.affiliation: Infectious Diseases and Clinical Virology, Merck Research Laboratories, Kenilworth, New Jersey, United States of America.
authors.forename: Anita Y M
authors.initials: AY
authors.lastname: Howe
authors.affiliation: Target & Pathway Biology, Merck Research Laboratories, Boston, Massachusetts, United States of America.
authors.forename: Joel A
authors.initials: JA
authors.lastname: Klappenbach
authors.affiliation: Molecular Biomarker and Diagnostics, Merck Research Laboratories, Rahway, New Jersey, United States of America.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Marton
mesh_terms: D005814:Genes, Viral; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis* / Q000821:virology; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D025202:Molecular Diagnostic Techniques; D058889:Molecular Typing; D010802:Phylogeny; D017422:Sequence Analysis, DNA
references.citation: Microb Biotechnol. 2015 Jan;8(1):93-102
references.pmid: 25042084
references.citation: Int J Med Sci. 2006;3(2):41-6
references.pmid: 16614741
references.citation: Nucleic Acids Res. 2008 Sep;36(16):e105
references.pmid: 18660515
references.citation: JAMA. 2014 Aug 13;312(6):631-40
references.pmid: 25117132
references.citation: Clin Infect Dis. 2014 Dec 15;59(12):1657-65
references.pmid: 25266289
references.citation: J Gen Virol. 1995 Sep;76 ( Pt 9):2329-35
references.pmid: 7561773
references.citation: J Virol Methods. 2003 May;109(2):187-93
references.pmid: 12711062
references.citation: J Clin Microbiol. 2008 Jan;46(1):192-7
references.pmid: 17989191
references.citation: J Biosci Bioeng. 2003;96(4):317-23
references.pmid: 16233530
references.citation: BMC Microbiol. 2002 Sep 25;2:29
references.pmid: 12323075
references.citation: Antivir Ther. 2009;14(4):467-79
references.pmid: 19578232
references.citation: Eur J Gastroenterol Hepatol. 2000 Jun;12(6):667-78
references.pmid: 10912488
references.citation: J Clin Microbiol. 2008 Jun;46(6):1901-6
references.pmid: 18400913
references.citation: N Engl J Med. 2014 May 15;370(20):1889-98
references.pmid: 24725239
references.citation: Science. 1989 Apr 21;244(4902):359-62
references.pmid: 2523562
references.citation: J Biomed Sci. 2009;16:62
references.pmid: 19586537
references.citation: Arch Virol. 2010 Dec;155(12):1977-87
references.pmid: 20842394
references.citation: Saudi J Kidney Dis Transpl. 2011 Jul;22(4):712-6
references.pmid: 21743215
references.citation: Liver Int. 2009 Jan;29 Suppl 1:74-81
references.pmid: 19207969
references.citation: J Clin Microbiol. 2007 Apr;45(4):1140-5
references.pmid: 17251399
references.citation: Bioinformatics. 2010 Jul 1;26(13):1669-70
references.pmid: 20472542
references.citation: Biotechniques. 2012 Feb;52(2):87-94
references.pmid: 22313406
references.citation: Curr Opin Virol. 2011 Nov;1(5):413-8
references.pmid: 22440844
references.citation: Genome Biol. 2011;12(2):R18
references.pmid: 21338519
references.citation: PLoS One. 2009;4(12):e8209
references.pmid: 19997618
references.citation: Clin Microbiol Infect. 2011 Feb;17(2):107-15
references.pmid: 21091831
references.citation: BMC Infect Dis. 2014;14 Suppl 5:S1
references.pmid: 25234810
references.citation: Bioinformatics. 2011 Nov 1;27(21):2957-63
references.pmid: 21903629
references.citation: Clin Chem Lab Med. 2007;45(2):167-70
references.pmid: 17311502
references.citation: J Virol Methods. 2010 Aug;167(2):205-7
references.pmid: 20362009
references.citation: Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
references.pmid: 7984417
references.citation: Clin Chem Lab Med. 2010 Apr;48(4):469-74
references.pmid: 20128734
references.citation: Antimicrob Agents Chemother. 2010 Sep;54(9):3641-50
references.pmid: 20585111
references.citation: Nucleic Acids Res. 2012 May;40(10):e72
references.pmid: 22323520